 | • レポートコード：QYR2104Z0665 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、無血管性壊死のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外傷関連無血管壊死（AVN）、非外傷関連無血管壊死（AVN））、用途別市場規模（病院、クリニック、診断センター、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・無血管性壊死の市場動向 ・企業の競争状況、市場シェア ・無血管性壊死の種類別市場規模（外傷関連無血管壊死（AVN）、非外傷関連無血管壊死（AVN）） ・無血管性壊死の用途別市場規模（病院、クリニック、診断センター、外来手術センター） ・無血管性壊死の北米市場規模2016-2027（アメリカ、カナダ） ・無血管性壊死のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・無血管性壊死のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・無血管性壊死の中南米市場規模2016-2027（メキシコ、ブラジル） ・無血管性壊死の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Stryker、Medtronic、Smith and Nephew、Ethicon、Sanofi、Bayer、Pfizer、Merck、Boehringer Ingelheim、Eli Lilly、Aurobindo Pharma、Integra LifeSciences、Zimmer Biomet、Wright Medical、Grifols） ・結論 |
Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby joint surface.
Known by other names such as osteonecrosis or bone infarction, the condition is gaining global awareness thus supporting the growth of the AVN market. The disease which more commonly afflicts men between the ages of 30 to 50 years, has been highly prevalent in emerging economies.
Market Analysis and Insights: Global Avascular Necrosis Market
The global Avascular Necrosis market size is projected to reach US$ 600.4 million by 2026, from US$ 473.8 million in 2019, at a CAGR of 3.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Avascular Necrosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Avascular Necrosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Avascular Necrosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Avascular Necrosis market.
Global Avascular Necrosis Scope and Market Size
Avascular Necrosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avascular Necrosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Trauma Related Avascular Necrosis (AVN)
Non-Trauma Related Avascular Necrosis (AVN)
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Stryker
Medtronic
Smith and Nephew
Ethicon
Sanofi
Bayer
Pfizer
Merck
Boehringer Ingelheim
Ethicon
Sanofi
Integra LifeSciences
Zimmer Biomet
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Avascular Necrosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Trauma Related Avascular Necrosis (AVN)
1.2.3 Non-Trauma Related Avascular Necrosis (AVN)
1.3 Market by Application
1.3.1 Global Avascular Necrosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Avascular Necrosis Market Perspective (2016-2027)
2.2 Avascular Necrosis Growth Trends by Regions
2.2.1 Avascular Necrosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Avascular Necrosis Historic Market Share by Regions (2016-2021)
2.2.3 Avascular Necrosis Forecasted Market Size by Regions (2022-2027)
2.3 Avascular Necrosis Industry Dynamic
2.3.1 Avascular Necrosis Market Trends
2.3.2 Avascular Necrosis Market Drivers
2.3.3 Avascular Necrosis Market Challenges
2.3.4 Avascular Necrosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Avascular Necrosis Players by Revenue
3.1.1 Global Top Avascular Necrosis Players by Revenue (2016-2021)
3.1.2 Global Avascular Necrosis Revenue Market Share by Players (2016-2021)
3.2 Global Avascular Necrosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Avascular Necrosis Revenue
3.4 Global Avascular Necrosis Market Concentration Ratio
3.4.1 Global Avascular Necrosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Avascular Necrosis Revenue in 2020
3.5 Avascular Necrosis Key Players Head office and Area Served
3.6 Key Players Avascular Necrosis Product Solution and Service
3.7 Date of Enter into Avascular Necrosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Avascular Necrosis Breakdown Data by Type
4.1 Global Avascular Necrosis Historic Market Size by Type (2016-2021)
4.2 Global Avascular Necrosis Forecasted Market Size by Type (2022-2027)
5 Avascular Necrosis Breakdown Data by Application
5.1 Global Avascular Necrosis Historic Market Size by Application (2016-2021)
5.2 Global Avascular Necrosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Avascular Necrosis Market Size (2016-2027)
6.2 North America Avascular Necrosis Market Size by Type
6.2.1 North America Avascular Necrosis Market Size by Type (2016-2021)
6.2.2 North America Avascular Necrosis Market Size by Type (2022-2027)
6.2.3 North America Avascular Necrosis Market Size by Type (2016-2027)
6.3 North America Avascular Necrosis Market Size by Application
6.3.1 North America Avascular Necrosis Market Size by Application (2016-2021)
6.3.2 North America Avascular Necrosis Market Size by Application (2022-2027)
6.3.3 North America Avascular Necrosis Market Size by Application (2016-2027)
6.4 North America Avascular Necrosis Market Size by Country
6.4.1 North America Avascular Necrosis Market Size by Country (2016-2021)
6.4.2 North America Avascular Necrosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Avascular Necrosis Market Size (2016-2027)
7.2 Europe Avascular Necrosis Market Size by Type
7.2.1 Europe Avascular Necrosis Market Size by Type (2016-2021)
7.2.2 Europe Avascular Necrosis Market Size by Type (2022-2027)
7.2.3 Europe Avascular Necrosis Market Size by Type (2016-2027)
7.3 Europe Avascular Necrosis Market Size by Application
7.3.1 Europe Avascular Necrosis Market Size by Application (2016-2021)
7.3.2 Europe Avascular Necrosis Market Size by Application (2022-2027)
7.3.3 Europe Avascular Necrosis Market Size by Application (2016-2027)
7.4 Europe Avascular Necrosis Market Size by Country
7.4.1 Europe Avascular Necrosis Market Size by Country (2016-2021)
7.4.2 Europe Avascular Necrosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Avascular Necrosis Market Size (2016-2027)
8.2 Asia-Pacific Avascular Necrosis Market Size by Type
8.2.1 Asia-Pacific Avascular Necrosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Avascular Necrosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Avascular Necrosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Avascular Necrosis Market Size by Application
8.3.1 Asia-Pacific Avascular Necrosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Avascular Necrosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Avascular Necrosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Avascular Necrosis Market Size by Region
8.4.1 Asia-Pacific Avascular Necrosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Avascular Necrosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Avascular Necrosis Market Size (2016-2027)
9.2 Latin America Avascular Necrosis Market Size by Type
9.2.1 Latin America Avascular Necrosis Market Size by Type (2016-2021)
9.2.2 Latin America Avascular Necrosis Market Size by Type (2022-2027)
9.2.3 Latin America Avascular Necrosis Market Size by Type (2016-2027)
9.3 Latin America Avascular Necrosis Market Size by Application
9.3.1 Latin America Avascular Necrosis Market Size by Application (2016-2021)
9.3.2 Latin America Avascular Necrosis Market Size by Application (2022-2027)
9.3.3 Latin America Avascular Necrosis Market Size by Application (2016-2027)
9.4 Latin America Avascular Necrosis Market Size by Country
9.4.1 Latin America Avascular Necrosis Market Size by Country (2016-2021)
9.4.2 Latin America Avascular Necrosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Avascular Necrosis Market Size (2016-2027)
10.2 Middle East & Africa Avascular Necrosis Market Size by Type
10.2.1 Middle East & Africa Avascular Necrosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Avascular Necrosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Avascular Necrosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Avascular Necrosis Market Size by Application
10.3.1 Middle East & Africa Avascular Necrosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Avascular Necrosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Avascular Necrosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Avascular Necrosis Market Size by Country
10.4.1 Middle East & Africa Avascular Necrosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Avascular Necrosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker Avascular Necrosis Introduction
11.1.4 Stryker Revenue in Avascular Necrosis Business (2016-2021)
11.1.5 Stryker Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Avascular Necrosis Introduction
11.2.4 Medtronic Revenue in Avascular Necrosis Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Smith and Nephew
11.3.1 Smith and Nephew Company Details
11.3.2 Smith and Nephew Business Overview
11.3.3 Smith and Nephew Avascular Necrosis Introduction
11.3.4 Smith and Nephew Revenue in Avascular Necrosis Business (2016-2021)
11.3.5 Smith and Nephew Recent Development
11.4 Ethicon
11.4.1 Ethicon Company Details
11.4.2 Ethicon Business Overview
11.4.3 Ethicon Avascular Necrosis Introduction
11.4.4 Ethicon Revenue in Avascular Necrosis Business (2016-2021)
11.4.5 Ethicon Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Avascular Necrosis Introduction
11.5.4 Sanofi Revenue in Avascular Necrosis Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Avascular Necrosis Introduction
11.6.4 Bayer Revenue in Avascular Necrosis Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Avascular Necrosis Introduction
11.7.4 Pfizer Revenue in Avascular Necrosis Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Avascular Necrosis Introduction
11.8.4 Merck Revenue in Avascular Necrosis Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Avascular Necrosis Introduction
11.9.4 Boehringer Ingelheim Revenue in Avascular Necrosis Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Avascular Necrosis Introduction
11.10.4 Eli Lilly Revenue in Avascular Necrosis Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Details
11.11.2 Aurobindo Pharma Business Overview
11.11.3 Aurobindo Pharma Avascular Necrosis Introduction
11.11.4 Aurobindo Pharma Revenue in Avascular Necrosis Business (2016-2021)
11.11.5 Aurobindo Pharma Recent Development
11.12 Integra LifeSciences
11.12.1 Integra LifeSciences Company Details
11.12.2 Integra LifeSciences Business Overview
11.12.3 Integra LifeSciences Avascular Necrosis Introduction
11.12.4 Integra LifeSciences Revenue in Avascular Necrosis Business (2016-2021)
11.12.5 Integra LifeSciences Recent Development
11.13 Zimmer Biomet
11.13.1 Zimmer Biomet Company Details
11.13.2 Zimmer Biomet Business Overview
11.13.3 Zimmer Biomet Avascular Necrosis Introduction
11.13.4 Zimmer Biomet Revenue in Avascular Necrosis Business (2016-2021)
11.13.5 Zimmer Biomet Recent Development
11.14 Wright Medical
11.14.1 Wright Medical Company Details
11.14.2 Wright Medical Business Overview
11.14.3 Wright Medical Avascular Necrosis Introduction
11.14.4 Wright Medical Revenue in Avascular Necrosis Business (2016-2021)
11.14.5 Wright Medical Recent Development
11.15 Grifols
11.15.1 Grifols Company Details
11.15.2 Grifols Business Overview
11.15.3 Grifols Avascular Necrosis Introduction
11.15.4 Grifols Revenue in Avascular Necrosis Business (2016-2021)
11.15.5 Grifols Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Avascular Necrosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Trauma Related Avascular Necrosis (AVN)
Table 3. Key Players of Non-Trauma Related Avascular Necrosis (AVN)
Table 4. Global Avascular Necrosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Avascular Necrosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Avascular Necrosis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Avascular Necrosis Market Share by Regions (2016-2021)
Table 8. Global Avascular Necrosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Avascular Necrosis Market Share by Regions (2022-2027)
Table 10. Avascular Necrosis Market Trends
Table 11. Avascular Necrosis Market Drivers
Table 12. Avascular Necrosis Market Challenges
Table 13. Avascular Necrosis Market Restraints
Table 14. Global Avascular Necrosis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Avascular Necrosis Market Share by Players (2016-2021)
Table 16. Global Top Avascular Necrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avascular Necrosis as of 2020)
Table 17. Ranking of Global Top Avascular Necrosis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Avascular Necrosis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Avascular Necrosis Product Solution and Service
Table 21. Date of Enter into Avascular Necrosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Avascular Necrosis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Avascular Necrosis Revenue Market Share by Type (2016-2021)
Table 25. Global Avascular Necrosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Avascular Necrosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Avascular Necrosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Avascular Necrosis Revenue Market Share by Application (2016-2021)
Table 29. Global Avascular Necrosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Avascular Necrosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Avascular Necrosis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Avascular Necrosis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Avascular Necrosis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Avascular Necrosis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Avascular Necrosis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Avascular Necrosis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Avascular Necrosis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Avascular Necrosis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Avascular Necrosis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Avascular Necrosis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Avascular Necrosis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Avascular Necrosis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Avascular Necrosis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Avascular Necrosis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Avascular Necrosis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Avascular Necrosis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Avascular Necrosis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Avascular Necrosis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Avascular Necrosis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Avascular Necrosis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Avascular Necrosis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Avascular Necrosis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Avascular Necrosis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Avascular Necrosis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Avascular Necrosis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Avascular Necrosis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Avascular Necrosis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Avascular Necrosis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Avascular Necrosis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Avascular Necrosis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Stryker Company Details
Table 62. Stryker Business Overview
Table 63. Stryker Avascular Necrosis Product
Table 64. Stryker Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 65. Stryker Recent Development
Table 66. Medtronic Company Details
Table 67. Medtronic Business Overview
Table 68. Medtronic Avascular Necrosis Product
Table 69. Medtronic Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 70. Medtronic Recent Development
Table 71. Smith and Nephew Company Details
Table 72. Smith and Nephew Business Overview
Table 73. Smith and Nephew Avascular Necrosis Product
Table 74. Smith and Nephew Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 75. Smith and Nephew Recent Development
Table 76. Ethicon Company Details
Table 77. Ethicon Business Overview
Table 78. Ethicon Avascular Necrosis Product
Table 79. Ethicon Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 80. Ethicon Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Avascular Necrosis Product
Table 84. Sanofi Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Avascular Necrosis Product
Table 89. Bayer Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Avascular Necrosis Product
Table 94. Pfizer Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Avascular Necrosis Product
Table 103. Boehringer Ingelheim Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly Avascular Necrosis Product
Table 108. Eli Lilly Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 109. Eli Lilly Recent Development
Table 110. Aurobindo Pharma Company Details
Table 111. Aurobindo Pharma Business Overview
Table 112. Aurobindo Pharma Avascular Necrosis Product
Table 113. Aurobindo Pharma Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 114. Aurobindo Pharma Recent Development
Table 115. Integra LifeSciences Company Details
Table 116. Integra LifeSciences Business Overview
Table 117. Integra LifeSciences Avascular Necrosis Product
Table 118. Integra LifeSciences Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 119. Integra LifeSciences Recent Development
Table 120. Zimmer Biomet Company Details
Table 121. Zimmer Biomet Business Overview
Table 122. Zimmer Biomet Avascular Necrosis Product
Table 123. Zimmer Biomet Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 124. Zimmer Biomet Recent Development
Table 125. Wright Medical Company Details
Table 126. Wright Medical Business Overview
Table 127. Wright Medical Avascular Necrosis Product
Table 128. Wright Medical Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 129. Wright Medical Recent Development
Table 130. Grifols Company Details
Table 131. Grifols Business Overview
Table 132. Grifols Avascular Necrosis Product
Table 133. Grifols Revenue in Avascular Necrosis Business (2016-2021) & (US$ Million)
Table 134. Grifols Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Avascular Necrosis Market Share by Type: 2020 VS 2027
Figure 2. Trauma Related Avascular Necrosis (AVN) Features
Figure 3. Non-Trauma Related Avascular Necrosis (AVN) Features
Figure 4. Global Avascular Necrosis Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Avascular Necrosis Report Years Considered
Figure 10. Global Avascular Necrosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Avascular Necrosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Avascular Necrosis Market Share by Regions: 2020 VS 2027
Figure 13. Global Avascular Necrosis Market Share by Regions (2022-2027)
Figure 14. Global Avascular Necrosis Market Share by Players in 2020
Figure 15. Global Top Avascular Necrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avascular Necrosis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Avascular Necrosis Revenue in 2020
Figure 17. Global Avascular Necrosis Revenue Market Share by Type (2016-2021)
Figure 18. Global Avascular Necrosis Revenue Market Share by Type (2022-2027)
Figure 19. North America Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Avascular Necrosis Market Share by Type (2016-2027)
Figure 21. North America Avascular Necrosis Market Share by Application (2016-2027)
Figure 22. North America Avascular Necrosis Market Share by Country (2016-2027)
Figure 23. United States Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Avascular Necrosis Market Share by Type (2016-2027)
Figure 27. Europe Avascular Necrosis Market Share by Application (2016-2027)
Figure 28. Europe Avascular Necrosis Market Share by Country (2016-2027)
Figure 29. Germany Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Avascular Necrosis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Avascular Necrosis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Avascular Necrosis Market Share by Region (2016-2027)
Figure 39. China Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Avascular Necrosis Market Share by Type (2016-2027)
Figure 47. Latin America Avascular Necrosis Market Share by Application (2016-2027)
Figure 48. Latin America Avascular Necrosis Market Share by Country (2016-2027)
Figure 49. Mexico Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Avascular Necrosis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Avascular Necrosis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Avascular Necrosis Market Share by Country (2016-2027)
Figure 55. Turkey Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Avascular Necrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Stryker Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 59. Medtronic Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 60. Smith and Nephew Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 61. Ethicon Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 68. Aurobindo Pharma Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 69. Integra LifeSciences Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 70. Zimmer Biomet Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 71. Wright Medical Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 72. Grifols Revenue Growth Rate in Avascular Necrosis Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の皮膚壊死治療市場規模・現状・予測（2021年-2027年） Acute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances of morbidity and loss of life. A thorough…- 世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年） Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of …
- 世界のGMP腫瘍壊死因子アルファ市場規模・現状・予測（2021年-2027年） Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of …
- 世界の骨盤外傷管理市場規模・現状・予測（2021年-2027年） The management of pelvic trauma patients aims definitively to restore the homeostasis and the normal physiopathology associated to the mechanical stability of the pelvic ring. The management of pelvic trauma must be multidisciplinary and should be ultimately based on the physiology of the patient an…
- 世界の加齢黄斑変性症（AMD）市場規模・現状・予測（2021年-2027年） Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated. Market Analysis and Insights: Global Age Related Macular Degeneration (AMD) Market The global Age Related Macular Degeneration (AMD) market size is projected to r…